Agios Pharmaceuticals, Inc.
AGIO· Nasdaq
AGIOAgios Pharmaceuticals, Inc.
Source filing unavailable
| Metric | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|
| Revenue | $14.64M | $6.74M | $6.28M |
| Net Income | -$26.66M | -$12.38M | -$5.31M |
| EPS Diluted | -$0.76 | -$0.40 | -$2.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Agios Pharmaceuticals, Inc. · CIK 1439222 · Engraved from SEC EDGAR
